arrow
V

Vivian H. Shih

late respiratory & immunology, biopharmaceuticals r&d, astrazeneca, gaithersburg, md, usa
H指数:11
被引数:1,094

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
2024-04-046
OAAI
Asthma outcomes in patients (pts) with severe eosinophilic asthma (SEA), with and without comorbid chronic rhinosinusitis with nasal polyps (NP), treated with benralizumab in the real-world XALOC-1 study
2023-10-270
PRE
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

贝那利珠单抗治疗慢性鼻-鼻窦炎伴鼻息肉的疗效和安全性: 一项随机、安慰剂对照试验

2022-04-01178
OA